A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid Tumors
Clinical trial NCT05084859 · TERMINATED
Trial details
- NCT number
- NCT05084859
- Sponsor
- Biosplice Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-03
- Primary completion
- 2022-10-20
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.